RVMDWRevolution Medicines Inc. Warrant
11.80USD-3.83%Mkt Cap: —P/E: —3d ago
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that bind…
Industry Peers
Financial ServicesKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit-1.30B $
Net Income (TTM)-1.13B $
Revenue/Share—
Last Price11.80 USD
Fiscal Year End—
MR Quarter—
Employees883
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.01
EPS (TTM)—
EPS (Forward)—
52W Range
1.79093% of range12.53
52W High12.53 USD
52W Low1.790 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-69.35%
ROA-48.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-897.74M $
CapEx (TTM)15.99M $
FCF Margin—
FCF Yield—
Net Debt-2.75B $
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.10
Current Ratio11.38
Quick Ratio11.12
Book Value/Sh12.16 USD
Cash/Share18.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float184.45M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.40
S&P 52W Chg18.16%
Avg Vol (30d)6.20K
Avg Vol (10d)—
Technical Indicators
RSI (14)83.9
MACD2.5345
MACD Signal1.7625
MACD Hist.+0.7720
BB Upper14.19 USD
BB Middle5.590 USD
BB Lower-3.0067 USD
BB Width307.58%
ATR (14)0.7954 USD
Vol Ratio (20d)0.72x